MINUTO, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 19.009
AS - Asia 1.793
NA - Nord America 1.477
SA - Sud America 138
Continente sconosciuto - Info sul continente non disponibili 50
AF - Africa 23
OC - Oceania 2
Totale 22.492
Nazione #
IT - Italia 18.739
US - Stati Uniti d'America 1.364
SG - Singapore 762
CN - Cina 428
VN - Vietnam 303
BD - Bangladesh 145
FR - Francia 130
BR - Brasile 80
HK - Hong Kong 51
CA - Canada 50
FI - Finlandia 35
AR - Argentina 27
JP - Giappone 25
DE - Germania 23
MX - Messico 21
GB - Regno Unito 20
CH - Svizzera 16
JM - Giamaica 15
ID - Indonesia 13
IQ - Iraq 13
EC - Ecuador 11
IE - Irlanda 10
CL - Cile 7
IN - India 6
SA - Arabia Saudita 6
UA - Ucraina 6
CR - Costa Rica 5
NL - Olanda 5
PH - Filippine 5
TH - Thailandia 5
VE - Venezuela 5
ZA - Sudafrica 5
CO - Colombia 4
GT - Guatemala 4
RU - Federazione Russa 4
AZ - Azerbaigian 3
BB - Barbados 3
BY - Bielorussia 3
ES - Italia 3
HN - Honduras 3
JO - Giordania 3
KE - Kenya 3
KR - Corea 3
KZ - Kazakistan 3
SE - Svezia 3
TN - Tunisia 3
UZ - Uzbekistan 3
AU - Australia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
MY - Malesia 2
NI - Nicaragua 2
PE - Perù 2
PK - Pakistan 2
PR - Porto Rico 2
PS - Palestinian Territory 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
LB - Libano 1
LC - Santa Lucia 1
LT - Lituania 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
NE - Niger 1
NG - Nigeria 1
OM - Oman 1
PL - Polonia 1
PY - Paraguay 1
RO - Romania 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SZ - Regno dello Swaziland 1
TG - Togo 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VI - Stati Uniti Isole Vergini 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 22.443
Città #
Genova 12.220
Genoa 3.734
Rapallo 1.625
Vado Ligure 1.056
San Jose 408
Singapore 366
Lauterbourg 123
Ashburn 114
Ho Chi Minh City 99
Beijing 86
Hanoi 59
New York 58
Hong Kong 49
Santa Clara 39
Helsinki 34
Tokyo 24
Frankfurt am Main 22
Los Angeles 21
Bordighera 20
Haiphong 18
Chicago 16
Zurich 15
Da Nang 12
Dallas 11
Orem 11
São Paulo 11
Buffalo 10
Dublin 10
Milan 10
Tianjin 10
Atlanta 9
Houston 9
Mexico City 9
Rome 9
San Francisco 9
Guayaquil 7
Montreal 7
Toronto 7
Cardiff 6
City of London 6
Kingston 6
Biên Hòa 5
Boston 5
Brooklyn 5
Charlotte 5
Milwaukee 5
Naples 5
Nashville 5
Philadelphia 5
Thái Bình 5
Tucson 5
Tulsa 5
Baghdad 4
Cleveland 4
Council Bluffs 4
Denver 4
Las Vegas 4
Newark 4
Phoenix 4
Queens 4
San José 4
Shanghai 4
Sterling Heights 4
The Bronx 4
Amsterdam 3
Aurora 3
Bensalem 3
Bridgetown 3
Bắc Ninh 3
Can Tho 3
Clearwater 3
Colorado Springs 3
Columbus 3
Durham 3
Elgin 3
Guangzhou 3
Huế 3
Hải Dương 3
Jacksonville 3
Joinville 3
Kyiv 3
Laval 3
Lomas de Zamora 3
London 3
Manchester 3
Nairobi 3
Newport News 3
Ninh Bình 3
Riyadh 3
Surabaya 3
Tashkent 3
Turin 3
Washington 3
Westerville 3
Winnipeg 3
Addis Ababa 2
Amman 2
Ancona 2
Anna 2
Baku 2
Totale 20.581
Nome #
Growth hormone secretion in pubertal and adult subjects. 268
Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone (GH) replacement therapy in adults with GH deficiency. 239
Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre. 236
Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system 235
Acromegaly is associated with increased cancer risk: A survey in Italy 222
SOMATOSTATIN AND DOPAMINE RECEPTOR INTERACTION IN PROSTATE AND LUNG CANCER CELL LINES 213
Effect of environment on growth: auxological and hormonal parameters in African and Italian children 213
Diabetes secondary to neuroendocrine gastroenteropancreatic tumors 211
Indirect evidence of hormone abuse. Proof of doping? 207
Pituitary image: pituicytoma. 205
Computed tomography colonography in acromegaly 205
Increasing hirsutism due to a granulosa-cell tumor in a woman with polycystic ovary syndrome: case report and review of the literature. 200
Absence of histological malignancy in a patient cohort with follicular lesions on fine-needle aspiration 199
Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and border-line value of the hormone 197
Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients 196
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology 196
Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease 194
Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases 194
Rapid pituitary tumor shrinkage with dissociation between antiproliferative and antisecretory effects of a long-acting octreotide in an acromegalic patient 192
Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease 191
A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma 191
Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study 189
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogs and dopastatins 188
Characterization of the IGF system in 15 patients with Alstrom syndrome. 188
Effects of the neuropeptide Y on estradiol and progesterone secretion by human granulosa cells in culture 186
Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience. 186
Diagnostic value of the acid-labile subunit in Acromegaly: Evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3 184
Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas 184
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth. 184
A unique association of clinical "persistent müllerian duct syndrome" and syringoid carcinoma of the perineal-scrotal skin: a consequence of urologic surgery? 183
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 182
Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue. 180
Effect of the somatostatin analog, octreotide, and of other hormones on the release of the acid-labile subunit of the 150 kDa complex by rat hepatocyte in primary culture. 180
The pathology of the ulnar nerve in acromegaly. 179
Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with turner's syndrome in culture 173
Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas 173
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation 171
Effect of the acid-labile subunit on the binding of insulin-like growth factor (IGF)-binding protein-3 to [125I]IGF-I. J.Clin.Endocrinol.Metab. 80 (4):1318-1324, 1995. 170
Circulating nitric oxide in women affected by weight loss amenorrhea during pulsatile gonadotropin-releasing hormone therapy 170
Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing 169
Therapeutic Strategies and Clinical Outcome in Papillary Thyroid Microcarcinoma: A Multicenter Observational Study. 169
Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns? 167
Pancreatic Islet Cell Tumor Secreting Insulin-Like Growth Factor Type-II in a Dog. 167
Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women 166
Paraneoplastic hypoglycemia due to an insulin-like growth factor type-II secreting hepatocellular carcinoma in a dog. 165
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities 164
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 164
Evidence for autocrine mitogenic stimulation by somatomedin- C/insulin-like growth factor I on an established human lung cancer cell line 164
Interrelationships between follicle stimulating hormone and the growth hormone--insulin-like growth factor--IGF-binding proteins axes in human granulosa cells in culture 163
Somatostatin receptor scintigraphy in thoracic diseases 162
Effects of growth hormone on leptin metabolism and energy expenditure in hemodialysis patients with protein-calorie malnutrition 162
Evidence for an increased somatomedin-C/insulin-like growth factor I content in primary human lung tumors 162
Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis. 161
Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly 161
Initial staging of lymphoma with octreotide and other receptor imaging agents. 160
Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients 159
Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population 158
Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments 158
Insulin treatment enhances expression of IGF-I in sural nerves of diabetic patients. 158
Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data. 158
Significant tumour shrinkage after 12 months of Lanreotide Autogel-120 mg treatment given first-line in acromegaly 157
STUDY OF BIOASSAYABLE SOMATOMEDIN ON RENAL ARTERY AND VEIN 156
Behaviour of typeII receptors of IGFs in different age and thyroid status in adult rat liver 156
Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cells in vitro. 156
Pituitary tumor disappearance in a patient with newly diagnosed acromegaly primarily treated with octreotide LAR 155
Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. 155
Effect of octreotide on circulating IGF-I chromatographic profile: evidence for an inhibitory action on the formation of the 150-kDa ternary complex 153
Papillary thyroid cancer in a struma ovarii: a report of a rare case 153
Sympathovagal imbalance in acromegalic patients 152
Decreased serum somatomedin C concentrations during sleep: temporal relationship to the nocturnal surges of growth hormone and prolactin. 152
Insulin-like growth factor I (IGF I) receptor autophosphorylation and kinase activity. Effect of a human polyclonal antibody (pIgG) 151
Trigger Finger, an Early Musculoskeletal Manifestation of Acromegaly 151
Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells 151
Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose. 150
Rationale and design of PATRO Adults, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope(R) for the treatment of adult patients with growth hormone deficiency 150
OR2,6 Interrelationship between somatostatin/dopamine pathways and growth factors in non-small lung cancer cells 149
Effects of alpha-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro. 148
P68 Insulin-like growth factor (IGF) binding protein-3 inhibits IGF-II-stimulated IRS-1/PI-3-kinase activity and cell growth in human non-small cell lung cancer (NSCLC) cell lines 148
Treatment of a pituitary metastasis from a neuroendocrine tumour: case report and literature review. 147
Cost-of-illness study in acromegalic patients in Italy 146
Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency. 146
Effects of microinflammation on growth hormone's sensitivity of potassium and amino acid metabolism in patients with chronic renal failure. 146
Wireless connections in a hospital ward: the WARD-IN-HAND Project 144
Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter. 144
P87 Effect of exenatide, sitagliptin and vildagliptin on IGF-I in diabetic patients 142
Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man. 140
Regulation Of Prostate Cancer Cell Proliferation By Somatostatin Receptor Activation 140
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5 140
Growth hormone response to clonidine in anovulatory infertile women resistant to clomiphene citrate stimulation 138
Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy 138
Current diagnostic guidelines for biochemical diagnosis of acromegaly. 138
Ultrasound measurement of median and ulnar nerve cross-sectional area in acromegaly. 138
Increased insulin-like growth factor (IGF)-II and IGF/IGF-binding protein ratio in prepubertal constitutionally tall children 138
Replacement therapy and cardiovascular diseases 137
In vivo and in vitro behavior of IGF system and Insulin receptor in polycystic ovaries (PCO) 136
Abstracts of the 6th Annual ENETS Conference, Granada, Spain, March 5–7, 2009 136
Ten years of gastroeneteropancreatic neuroendocrine tumors: is reclassification Worth while? 135
Potential indications for somatostatin analogues: immune system and lymphoproliferative disorders 134
The undescended testis. Prevalence and clinical features 133
Sympathovagal imbalance in transsexual subjects. 132
Totale 16.882
Categoria #
all - tutte 66.010
article - articoli 61.855
book - libri 0
conference - conferenze 2.892
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.263
Totale 132.020


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.863 35 97 168 233 72 128 134 434 89 174 58 241
2022/20231.937 177 143 37 227 310 351 3 130 303 5 226 25
2023/2024782 41 105 12 114 65 128 51 46 46 14 57 103
2024/20252.650 53 183 76 172 389 247 281 435 103 86 277 348
2025/20264.293 535 95 214 318 616 388 747 175 287 352 239 327
2026/2027565 565 0 0 0 0 0 0 0 0 0 0 0
Totale 22.492